| PET imaging of tau deposition in the aging human brain M Schöll, SN Lockhart, DR Schonhaut, JP O’Neil, M Janabi, ... Neuron 89 (5), 971-982, 2016 | 1155 | 2016 |
| Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease R Ossenkoppele, DR Schonhaut, M Schöll, SN Lockhart, N Ayakta, ... Brain 139 (5), 1551-1567, 2016 | 1071 | 2016 |
| Episodic memory loss is related to hippocampal-mediated β-amyloid deposition in elderly subjects EC Mormino, JT Kluth, CM Madison, GD Rabinovici, SL Baker, BL Miller, ... Brain 132 (5), 1310-1323, 2009 | 775 | 2009 |
| Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease A Bejanin, DR Schonhaut, R La Joie, JH Kramer, SL Baker, N Sosa, ... Brain 140 (12), 3286-3300, 2017 | 653 | 2017 |
| Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... Science translational medicine 12 (524), eaau5732, 2020 | 461 | 2020 |
| 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration GD Rabinovici, AJ Furst, JP O'neil, CA Racine, EC Mormino, SL Baker, ... Neurology 68 (15), 1205-1212, 2007 | 439 | 2007 |
| Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease A Maass, S Landau, SL Baker, A Horng, SN Lockhart, R La Joie, ... Neuroimage 157, 448-463, 2017 | 419 | 2017 |
| Striatal dopamine and working memory SM Landau, R Lal, JP O'Neil, S Baker, WJ Jagust Cerebral cortex 19 (2), 445-454, 2009 | 353 | 2009 |
| Relationships between beta-amyloid and functional connectivity in different components of the default mode network in aging EC Mormino, A Smiljic, AO Hayenga, S H. Onami, MD Greicius, ... Cerebral cortex 21 (10), 2399-2407, 2011 | 345 | 2011 |
| Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease G Mittermeyer, CW Christine, KH Rosenbluth, SL Baker, P Starr, P Larson, ... Human gene therapy 23 (4), 377-381, 2012 | 332 | 2012 |
| Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios SM Landau, A Fero, SL Baker, R Koeppe, M Mintun, K Chen, EM Reiman, ... Journal of Nuclear Medicine 56 (4), 567-574, 2015 | 327 | 2015 |
| Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden GD Rabinovici, AJ Furst, A Alkalay, CA Racine, JP O’Neil, M Janabi, ... Brain 133 (2), 512-528, 2010 | 302 | 2010 |
| Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers SM Landau, BA Thomas, L Thurfjell, M Schmidt, R Margolin, M Mintun, ... European journal of nuclear medicine and molecular imaging 41, 1398-1407, 2014 | 297 | 2014 |
| Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752, 2021 | 295 | 2021 |
| Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging A Maass, SN Lockhart, TM Harrison, RK Bell, T Mellinger, K Swinnerton, ... Journal of Neuroscience 38 (3), 530-543, 2018 | 271 | 2018 |
| Longitudinal tau accumulation and atrophy in aging and alzheimer disease TM Harrison, R La Joie, A Maass, SL Baker, K Swinnerton, L Fenton, ... Annals of neurology 85 (2), 229-240, 2019 | 249 | 2019 |
| Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data SL Baker, A Maass, WJ Jagust Data in brief 15, 648-657, 2017 | 237 | 2017 |
| Sleep as a potential biomarker of tau and β-amyloid burden in the human brain JR Winer, BA Mander, RF Helfrich, A Maass, TM Harrison, SL Baker, ... Journal of Neuroscience 39 (32), 6315-6324, 2019 | 215 | 2019 |
| Neural compensation in older people with brain amyloid-β deposition JA Elman, H Oh, CM Madison, SL Baker, JW Vogel, SM Marks, S Crowley, ... Nature neuroscience 17 (10), 1316-1318, 2014 | 199 | 2014 |
| Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission … R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ... JAMA neurology 78 (8), 961-971, 2021 | 198 | 2021 |
